|
|
Article: Spectrum Pharmaceuticals Reports Fiscal Year 2008 Corporate Update and Pipeline Review.
- Article from:
- Health & Beauty Close-Up
- Article date:
- April 1, 2009
CopyrightCOPYRIGHT 2009 Close-Up Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Spectrum Pharmaceuticals, Inc.has reported financial results for the fourth quarter and fiscal year ended December 31.
"We achieved a critical milestone in 2008 - the transition from a research and development to a commercial organization," said Rajesh C. Shrotriya, M.D., Chairman, Chief Executive Officer, and President of Spectrum Pharmaceuticals. "Spectrum derives revenues from two FDA-approved, proprietary oncology drugs, has a late stage pipeline of novel products focused primarily on oncology and urology, and has a balanced business strategy involving judicious monetization of assets and fiscal discipline, executed by a highly experienced management team. As ...